1Gonzalez A, Lopez B, Querejeta R, et al. Regulation of myocardial flbrillar collagen by angiotensin Ⅱ. A role in hypertensive heart disease? J Mol Cell Cardiol, 2002,34:1585-1593.
2Weber KT, Sun Y, Campbell SE. Structural remodeling of the heart by fibrous tissue: Role of circulating hormones and locally produced peptides. Eur Heart J, 1995,16(Suppl N) :12-18.
3Zou Y,Komuro I,Yamazaki T, et al. Cell type specific angiotensin Ⅱ evoked signal traneduction pathways. Circ Res, 1998, 82 : 337-345.
4Reddy HK, Campbell SE, Janicki JS, et al. Coronary microvascular fluid flux and permeability influence of anglo- tensin Ⅱ aldosterone and arterial hypertension. J Lab Clin Med, 1993, 121:510-521.
6Tokuda K, Kai H, Kuwahara F, et al. Pressure-independent effects of angiotensin Ⅱ on hypertensive myocardial fibrosis. Hypertension,2004,43 : 499-503.
7Brilla CG. Aldosterone and myocardial fibrosis in heart failure.Herz, 2000,25:299-306.
8Lopez B, Quercjeta R, Varo N, et al. Usefulness of serum carboxy-terminal propeptide of procollagen type Ⅰ in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients. Circulation, 2001, 104:286-291.
9Taylor K, Patten RD, Smith J, et al. Divergent effects of angiotensing-converting enzyme inhibition and angiotensin Ⅱ receptor antagonis monmyocardial cellular proliferation and collagen deposition after myocardial infarction in rats. J Cardiovasc Pharmacol, 1998,31:654-667.
10Yoshida J, Yamamoto K, Mano T, et al. AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart failure. Hypertension, 2004,43 : 686-691.
